Genitourinary Cancers

This book addresses the most pressing current questions in the management of urologic malignancies. The rapid advances in imaging and molecular markers are placed into a clinical context, with explanation of their effects on prognosis and treatment planning. Similarly, progress in immunotherapy is c...

Celý popis

Uloženo v:
Podrobná bibliografie
Médium: Elektronický zdroj E-kniha
Jazyk:angličtina
Vydáno: Cham : Springer International Publishing, 2018.
Vydání:1st ed. 2018.
Edice:Cancer Treatment and Research, 175
Témata:
ISBN:9783319933399
ISSN:0927-3042 ;
On-line přístup: Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

MARC

LEADER 00000nam a22000005i 4500
003 SK-BrCVT
005 20220618120141.0
007 cr nn 008mamaa
008 180831s2018 gw | s |||| 0|eng d
020 |a 9783319933399 
024 7 |a 10.1007/978-3-319-93339-9  |2 doi 
035 |a CVTIDW09671 
040 |a Springer-Nature  |b eng  |c CVTISR  |e AACR2 
041 |a eng 
245 1 0 |a Genitourinary Cancers   |h [electronic resource] /  |c edited by Siamak Daneshmand, Kevin G. Chan. 
250 |a 1st ed. 2018. 
260 1 |a Cham :  |b Springer International Publishing,  |c 2018. 
300 |a VI, 308 p. 39 illus., 38 illus. in color.  |b online resource. 
490 1 |a Cancer Treatment and Research,  |x 0927-3042 ;  |v 175 
500 |a Medicine  
505 0 |a New Imaging Techniques in Prostate Cancer -- Targeted ablative therapies for prostate cancer -- Prostate cancer markers -- Prognostic value of CTC's in urologic cancers -- Management of Small Renal Masses -- Advances in the Treatment of Metastatic Renal Cell Carcinoma.-Imaging in urologic cancers -- Molecular prognostication in Bladder cancer -- Early cystectomy for high risk non-muscle invasive disease -- Care-coordination pathway after radical cystectomy -- Current role of checkpoint inhibitors in urologic cancers -- ) The Cancer Genome Atlas Project -- Prognostic models in germ cell tumors -- Modern management of testicular cancer. 
516 |a text file PDF 
520 |a This book addresses the most pressing current questions in the management of urologic malignancies. The rapid advances in imaging and molecular markers are placed into a clinical context, with explanation of their effects on prognosis and treatment planning. Similarly, progress in immunotherapy is carefully examined, focusing in particular on the role of immune checkpoint inhibitors in both early- and late-stage urologic malignancies. Looking beyond the improvements in minimally invasive techniques for urologic cancers, the impacts of care coordination pathways and enhanced recovery after surgery protocols are reviewed. Readers will also find enlightening discussion of the decision algorithm for the treatment of early-stage, high-grade bladder cancer, taking into account evidence on the most advanced treatment options and the circumstances in which surgery may need to be expedited. The penultimate chapter discusses the Cancer Genome Atlas project for bladder cancer, and the book closes by considering contemporary medical and surgical management of testicular cancer. 
650 0 |a Oncology . 
650 0 |a Urology. 
856 4 0 |u http://hanproxy.cvtisr.sk/han/cvti-ebook-springer-eisbn-978-3-319-93339-9  |y Vzdialený prístup pre registrovaných používateľov 
910 |b ZE06951 
919 |a 978-3-319-93339-9 
974 |a andrea.lebedova  |f Elektronické zdroje 
992 |a SUD 
999 |c 274524  |d 274524